Profil
Per Ingvar Oskar Wikström is the founder and currently serves as the Chief Executive Officer & Director of Glucox Biotech AB, a company founded in 2003.
He has also held former positions as a Principal at Immunex Corp., Pfizer Inc., and Pharmacia, Inc.
Postes actifs de Per Ingvar Oskar Wikström
| Sociétés | Poste | Début |
|---|---|---|
Glucox Biotech AB
 Glucox Biotech AB Pharmaceuticals: MajorHealth Technology Glucox Biotech AB is a holding company. It develops clinically applicable therapeutics for treatment of type 2 diabetes; hyperglycaemia, insulin resistance and resulting complications. The firm explores new ideas for the prevention of cellular damage in ischemic stroke and heart infarction, as well the idea behind Glucox Biotech's therapies is to reduce oxidative stress by preventing the intracellular formation of reactive oxygen species. The company was founded by Ellen Mona Gratia Wilcke and Per Ingvar O. Wikström on July 1, 2003 and is headquartered in Stockholm, Sweden. | Fondateur | 01/07/2003 |
Anciens postes connus de Per Ingvar Oskar Wikström
| Sociétés | Poste | Fin |
|---|---|---|
| Pharmacia, Inc. | Corporate Officer/Principal | - |
| PFIZER, INC. | Corporate Officer/Principal | - |
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Immunex Corp.
Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Health Technology |
| Pharmacia, Inc. | |
Glucox Biotech AB
Glucox Biotech AB Pharmaceuticals: MajorHealth Technology Glucox Biotech AB is a holding company. It develops clinically applicable therapeutics for treatment of type 2 diabetes; hyperglycaemia, insulin resistance and resulting complications. The firm explores new ideas for the prevention of cellular damage in ischemic stroke and heart infarction, as well the idea behind Glucox Biotech's therapies is to reduce oxidative stress by preventing the intracellular formation of reactive oxygen species. The company was founded by Ellen Mona Gratia Wilcke and Per Ingvar O. Wikström on July 1, 2003 and is headquartered in Stockholm, Sweden. | Health Technology |
